The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …

At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation
of a stent, often a drug-eluting stent, though most published data originated in the era of bare …

Background Treatment of coronary in-stent restenosis is hampered by a high incidence of
recurrent in-stent restenosis. We assessed the efficacy and safety of a paclitaxel-coated …

Background—The optimal stenting strategy in coronary artery bifurcation lesions is
unknown. In the present study, a strategy of stenting both the main vessel and the side …

From the Publisher: This objective, referenced collection of over 300 articles will cover every
aspect of medical devices and instrumentation in four volumes, totalling about 3,000 pages …

that support either the 2001 recommendations that have changed or the new or revised
recommendations are cited in parentheses at the end of each recommendation or comment …

ContextIn patients with de novo coronary lesions, drug-eluting stents have drastically
reduced restenosis risk compared with bare metal stents and conventional balloon …

Background—The effectiveness of sirolimus-eluting stents in unselected patients treated in
the daily practice is currently unknown. Methods and Results—Sirolimus-eluting stent …

The current state-of-the-art with respect to the preparation, characterization and biomedical
applications of novel nitric oxide (NO) releasing or generating polymeric materials is …

Background—We used intravascular ultrasound (IVUS) to evaluate recurrence after
sirolimus-eluting stent (SES) implantation treatment of in-stent restenosis (ISR). Methods …